Clinical Microbiology Reviews

Papers
(The median citation count of Clinical Microbiology Reviews is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility381
Extracutaneous sporotrichosis218
Transmission of Infections during Cardiopulmonary Resuscitation183
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections169
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders139
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease135
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”127
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives118
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance117
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant117
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves113
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus112
Progression of antibiotic resistance in Neisseria meningitidis101
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases90
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options88
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities82
Viral infections and pathogenesis of glaucoma: a comprehensive review82
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory80
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review79
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance79
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics75
Evolutionary Pathways and Trajectories in Antibiotic Resistance75
Review of BCG immunotherapy for bladder cancer71
Neisseria gonorrhoeae vaccines: a contemporary overview71
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen70
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control69
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms68
Congenital Syphilis: a Review of Global Epidemiology63
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature62
Bacterial and fungal infections in persons who inject drugs61
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease61
BCG therapy in bladder cancer and its tumor microenvironment interactions59
Diagnosis, Management, and Future Control of Cholera57
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes55
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections55
Rapid and accurate testing for urinary tract infection: new clothes for the emperor54
Trained Immunity as a Preventive Measure for Surgical Site Infections53
Aspergillus terreus Species Complex52
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome50
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)49
Harnessing the host response for precision infectious disease diagnosis48
Agnostic Sequencing for Detection of Viral Pathogens48
2021 Acknowledgment of CMR Reviewers46
Artemisinin-resistant malaria46
Editorial Board46
Pneumocystis jirovecii pneumonia in people living with HIV: a review45
COVID-19 therapeutics43
Pathogenesis of viral infections during pregnancy42
The challenges of difficult-to-treat Acinetobacter infections42
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response40
The oral penems and carbapenems40
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing39
Editorial Board37
Editorial Board34
Human toxocariasis34
Invasive fusariosis31
Updated Review onNocardiaSpecies: 2006–202131
Osteoarticular Mycoses30
Natural-Product-Based Solutions for Tropical Infectious Diseases30
SARS-CoV-2 Antiviral Therapy30
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease30
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence28
Schistosomiasis: cercarial finding and recognizing of human hosts as a prerequisite of invasion27
Clinical Microbiology Reviews : a 21st century vision26
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis26
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management24
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective24
Skin microbiota in atopic dermatitis: victim or executioner?23
Host Immunity and Immunization Strategies for Clostridioides difficile Infection22
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream22
Surveillance and prevention of infection in clinical xenotransplantation21
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities21
Current perspectives in the epidemiology and control of lymphatic filariasis21
Advancements and challenges in antifungal therapeutic development20
Masks and respirators for prevention of respiratory infections: a state of the science review20
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis20
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era19
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”19
A call for the United States to continue investing in science19
Human Listeriosis18
Prion Dissemination through the Environment and Medical Practices: Facts and Risks for Human Health18
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections18
Neurological complications caused by SARS-CoV-217
Fastidious or rarely isolated gram-negative rods with a particular focus on Kingella kingae17
2023 Acknowledgment of CMR Reviewers17
Optimized use and performance of culture for periprosthetic joint infection diagnosis: a comprehensive literature review17
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies16
2024 Acknowledgment of CMR Reviewers15
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells15
American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis15
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection14
Adoptive T-cell therapy for virus-associated diseases14
Monkeypox Virus Infections in Humans13
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials13
Recent advances in therapeutic probiotics: insights from human trials12
Genital cutaneous candidiasis versus chronic recurrent vulvovaginal candidiasis: distinct diseases, different populations12
Laboratory detection of carbapenemases among Gram-negative organisms12
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management12
0.12651991844177